.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Breast cancer remains one of the most prevalent malignancies affecting women worldwide. Recent transcriptomic studies have highlighted the importance of metabolic reprogramming in the tumor microenvironment. Specifically, the role of LIPE in breast cancer has emerged as a significant factor in regulating tumor growth and immune evasion. Lipase E, also known as hormone-sensitive lipase, plays a vital part in breaking down fats. However, its specific molecular mechanisms in oncology have remained largely elusive until recently. Researchers now believe that LIPE acts as a critical regulator of lipid metabolism and the behavior of immune cells within the tumor.
Lipid metabolism is central to how cancer cells obtain energy and build membranes. In breast cancer tissues, LIPE is often significantly downregulated compared to healthy tissues. Consequently, when LIPE levels are low, the balance of fatty acids shifts, which often favors tumor progression. Overexpressing LIPE in experimental models leads to several notable changes. For instance, it increases free fatty acid levels and lipoprotein lipase activity. Simultaneously, it decreases the expression of fatty acid synthase and ATP-citrate lyase. These enzymatic changes effectively reduce the ability of breast cancer cells to proliferate, migrate, and invade surrounding tissues.
The immune microenvironment is equally important in determining the fate of a tumor. Macrophages, a type of white blood cell, can either fight the tumor or help it grow depending on their polarization. Pro-tumor macrophages, often labeled as M2-like, typically express markers like CD206. Interestingly, LIPE in breast cancer influences this polarization process. Higher levels of LIPE lead to a reduction in CD206-positive cells. This shift is accompanied by a decrease in immunosuppressive cytokines such as interleukin-10 and transforming growth factor-beta 1. Instead, it promotes the release of pro-inflammatory signals like interleukin-1beta, which helps the body mount a more effective anti-tumor response.
Understanding the dual role of LIPE in metabolism and immunity provides a roadmap for new therapeutic strategies. Since LIPE overexpression reduces tumor volume and weight in vivo, targeting this pathway could enhance existing treatments. Furthermore, the correlation between lipid droplet regulation and leukocyte migration suggests that metabolic interventions might improve the efficacy of immunotherapies. Future research will likely focus on how to pharmacologically restore LIPE activity in patients with advanced breast cancer. This approach could potentially turn the metabolic and immune environment against the tumor.
The LIPE gene regulates the breakdown of lipids within the tumor microenvironment. In breast cancer, it often acts as a tumor suppressor by limiting the energy available for cancer cell growth and migration.
LIPE influences the polarization of tumor-associated macrophages. It reduces the presence of M2-like macrophages that promote tumor growth and encourages a more inflammatory, anti-tumor immune environment.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Feng X et al. Transcriptomic analysis reveals the regulatory role of LIPE in lipid metabolism and tumor-associated macrophage polarization in breast cancer. Pathol Res Pract. 2026 May 16. doi: undefined. PMID: 42143557.
Li M et al. Lipid metabolism-associated immune gene LPL promotes M1 macrophage polarization and inhibits breast cancer progression. Tissue Cell. 2025;97:103071. doi: 10.1016/j.tice.2025.103071.
Wu Z et al. FABP4-mediated lipid accumulation and lipolysis in tumor associated macrophages promote breast cancer metastasis. eLife. 2024;13:RP98765. doi: 10.7554/eLife.98765.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New research identifies LIPE as a key regulator of lipid metabolism and macrophage polarization, offering fresh insights into breast cancer therapy targets....
5 months ago
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today
This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
